Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency

Thyroid

Volumn 10, Issue 12, 2000, Pages 1081-1085

  Rotondi, M ^a   Amato, G ^a   Del Buono, A ^a   Mazziotti, G ^a   Manganella, G ^a   Biondi, B ^a   Sinisi, A M ^a   Santini, L ^a   Bellastella, A ^a   Carella, C ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROTROPIN;

ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFICACY; FEMALE; HUMAN; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; THYROID FUNCTION; THYROID SURGERY; THYROTROPIN BLOOD LEVEL; TREATMENT PLANNING;

EID: 0034505680     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.1081     Document Type: Article

References (24)

1. Endemic goiter and endemic thyroid disorders
2. Recurrence of non-toxic goitre with and without postoperative thyroxine medication
3. Postoperative goitre recurrence rate in Turkey
4. Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: Result at the third year of follow-up
5. Preventive effect of levothyroxine in patients operated for non-toxic goitre: A randomized trial of one hundred patients with nine years follow-up
6. Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified?
7. Thyroid hormone suppressive therapy of sporadic nontoxic goiter
8. Triiodiothyronine and thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning
9. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters
10. Postoperative thyroid hormone therapy in nontoxic goitre
11. Management of goiter and thyroid nodules in an area of endemic goiter
12. Does prophylactic thyroxine treatment after operation for nontoxic goitre influence thyroid size?
13. Indications for thyroxine therapy after surgery for nontoxic benign goitre
14. Secondary thyroidectomy: A twenty-year experience
15. Nodular goiter - Is thyroxine medication of any value?
16. The long-term outcome of thyroidectomy for sporadic non-toxic goitre
17. Thyroxine suppression therapy for benign nodular disease
18. Thyroid morphology and function after surgical treatment of thyroid diseases
19. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine
20. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons
21. Effects on bone mass of long term treatment with thyroid hormones: A meta-analysis
22. Impaired cardiac reserve and exercise capacity in patients receiving long term thyrotropin suppressive therapy with L-T4
23. Treatment of benign nodular thyroid disease
24. Thyroxine suppressive therapy in patients with nodular thyroid disease